Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 1
2009 3
2010 2
2011 4
2012 3
2013 2
2014 1
2017 1
2020 2
2022 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
EGFR signaling in breast cancer: bad to the bone.
Foley J, Nickerson NK, Nam S, Allen KT, Gilmore JL, Nephew KP, Riese DJ 2nd. Foley J, et al. Semin Cell Dev Biol. 2010 Dec;21(9):951-60. doi: 10.1016/j.semcdb.2010.08.009. Epub 2010 Sep 9. Semin Cell Dev Biol. 2010. PMID: 20813200 Free PMC article. Review.
The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein.
Lucas LM, Dwivedi V, Senfeld JI, Cullum RL, Mill CP, Piazza JT, Bryant IN, Cook LJ, Miller ST, Lott JH 4th, Kelley CM, Knerr EL, Markham JA, Kaufmann DP, Jacobi MA, Shen J, Riese DJ 2nd. Lucas LM, et al. Pharmacol Rev. 2022 Jan;74(1):18-47. doi: 10.1124/pharmrev.121.000381. Pharmacol Rev. 2022. PMID: 34987087 Free PMC article. Review.
Epiregulin: roles in normal physiology and cancer.
Riese DJ 2nd, Cullum RL. Riese DJ 2nd, et al. Semin Cell Dev Biol. 2014 Apr;28:49-56. doi: 10.1016/j.semcdb.2014.03.005. Epub 2014 Mar 12. Semin Cell Dev Biol. 2014. PMID: 24631357 Free PMC article. Review.
Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeutics.
Cullum RL, Lucas LM, Senfeld JI, Piazza JT, Neel LT, Whig K, Zhai L, Harris MH, Rael CC, Taylor DC, Cook LJ, Kaufmann DP, Mill CP, Jacobi MA, Smith FT, Suto M, Bostwick R, Gupta RB, David AE, Riese Ii DJ. Cullum RL, et al. PLoS One. 2020 Dec 30;15(12):e0243901. doi: 10.1371/journal.pone.0243901. eCollection 2020. PLoS One. 2020. PMID: 33378376 Free PMC article.
Inter-conversion of neuregulin2 full and partial agonists for ErbB4.
Wilson KJ, Mill CP, Cameron EM, Hobbs SS, Hammer RP, Riese DJ 2nd. Wilson KJ, et al. Biochem Biophys Res Commun. 2007 Dec 14;364(2):351-7. doi: 10.1016/j.bbrc.2007.10.004. Epub 2007 Oct 11. Biochem Biophys Res Commun. 2007. PMID: 17945187 Free PMC article.
20 results